Filing Details

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2(a)

(Amendment No. 3)

 

 

LCNB Corp.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

50181P100

(CUSIP Number)

John C. Lame

8805 Tamiami Trail N. #128

Naples, FL 34108

Telephone: (513) 235-6982

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

January 19, 2022

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ☐

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 50181P100

 

1		NAME OF REPORTING PERSONS   I.R.S. Identification Nos. of above persons (entities only).     John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*   (a)  ☒        (b)  ☐
3		SEC USE ONLY
4		SOURCE OF FUNDS     PF
5		CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
6		CITIZENSHIP OR PLACE OF ORGANIZATION     Florida

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH				7		SOLE VOTING POWER
				8		SHARED VOTING POWER     695,000 (1)
				9		SOLE DISPOSITIVE POWER
				10		SHARED DISPOSITIVE POWER     695,000 (1)

11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     695,000
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     5.59% (2)
14		TYPE OF REPORTING PERSON     OO

 

(1)	695,000 shares of common stock owned by the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018, a Florida trust, of which John C. Lame and Susan K. Lame serve as joint trustees and share voting and dispositive power with regard to the shares held by the trust.

(2)	Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuers Form 10-Q filed with the Securities and Exchange Commission (the SEC) on November 3, 2021.

 

2

CUSIP No. 50181P100

 

1		NAME OF REPORTING PERSONS   I.R.S. Identification Nos. of above persons (entities only).     John C. Lame IRA
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*   (a)  ☒        (b)  ☐
3		SEC USE ONLY
4		SOURCE OF FUNDS     PF
5		CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
6		CITIZENSHIP OR PLACE OF ORGANIZATION     Florida

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH				7		SOLE VOTING POWER     144,580 (1)
				8		SHARED VOTING POWER
				9		SOLE DISPOSITIVE POWER     144,580 (1)
				10		SHARED DISPOSITIVE POWER

11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     144,580 (1)
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     1.16% (2)
14		TYPE OF REPORTING PERSON     OO

 

(1)	John C. Lame is the trustee of the John C. Lame IRA and in such capacity has the right to vote and dispose of the securities held by the IRA.

(2)	Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuers Form 10-Q filed with the SEC on November 3, 2021.

 

3

CUSIP No. 50181P100

 

1		NAME OF REPORTING PERSONS   I.R.S. Identification Nos. of above persons (entities only).     John C. Lame Roth Contributory IRA
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*   (a)  ☒        (b)  ☐
3		SEC USE ONLY
4		SOURCE OF FUNDS     PF
5		CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
6		CITIZENSHIP OR PLACE OF ORGANIZATION     Florida

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH				7		SOLE VOTING POWER     83,170 (1)
				8		SHARED VOTING POWER
				9		SOLE DISPOSITIVE POWER     83,170 (1)
				10		SHARED DISPOSITIVE POWER

11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     83,170 (1)
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     .67% (2)
14		TYPE OF REPORTING PERSON     IN

 

(1)	John C. Lame is the trustee of the John C. Lame Roth Contributory IRA and in such capacity has the right to vote and dispose of the securities held by the Roth IRA.

(2)	Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuers Form 10-Q filed with the SEC on November 3, 2021.

 

4

CUSIP No. 50181P100

 

1		NAME OF REPORTING PERSONS   I.R.S. Identification Nos. of above persons (entities only).     Susan K. Lame Roth Contributory IRA
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*   (a)  ☒        (b)  ☐
3		SEC USE ONLY
4		SOURCE OF FUNDS     PF
5		CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
6		CITIZENSHIP OR PLACE OF ORGANIZATION     Florida

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH				7		SOLE VOTING POWER     48,450 (1)
				8		SHARED VOTING POWER
				9		SOLE DISPOSITIVE POWER     48,450 (1)
				10		SHARED DISPOSITIVE POWER

11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     48,450 (1)
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     .39% (2)
14		TYPE OF REPORTING PERSON     IN

 

(1)	Susan K. Lame is the trustee of the Susan K. Lame Roth Contributory IRA and in such capacity has the right to vote and dispose of the securities held by the Roth IRA.

(2)	Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuers Form 10-Q filed with the SEC on November 3, 2021.

 

5

CUSIP No. 50181P100

 

1		NAME OF REPORTING PERSONS   I.R.S. Identification Nos. of above persons (entities only).     Susan K. Lame IRA
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*   (a)  ☒        (b)  ☐
3		SEC USE ONLY
4		SOURCE OF FUNDS     PF
5		CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
6		CITIZENSHIP OR PLACE OF ORGANIZATION     Florida

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH				7		SOLE VOTING POWER     56,125 (1)
				8		SHARED VOTING POWER
				9		SOLE DISPOSITIVE POWER     56,125 (1)
				10		SHARED DISPOSITIVE POWER

11		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     56,125 (1)
12		CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
13		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)     .45% (2)
14		TYPE OF REPORTING PERSON     OO

 

(1)	Susan K. Lame is the trustee of the Susan K. Lame IRA and in such capacity has the right to vote and dispose of the securities held by the IRA.

(2)	Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuers Form 10-Q filed with the SEC on November 3, 2021.

 

6

CUSIP No. 50181P100

 

Item 1.

Security and Issuer

This Schedule 13D relates to shares of common stock, without par value, of LCNB Corp., an Ohio corporation (the Issuer). The Issuers principal executive office is located at 2 North Broadway, Lebanon, Ohio 45036.

 

Item 2.

Identity and Background

This Schedule 13D is jointly filed by John C. Lame and Susan K. Lame, Mr. Lames spouse, in their capacities as co-trustees of the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018 (the Trust); the John C. Lame IRA; the John C. Lame Roth Contributory IRA (the John Lame Roth IRA); the Susan K. Lame IRA; and the Susan K. Lame Roth Contributory IRA (the Susan Lame Roth IRA) (collectively, the Reporting Persons). Item 2 is amended by the filing of this Amendment No. 3 to add the Susan K. Lame IRA as a Reporting Person. Amendment No. 3 also amends Amendment No. 2 by reporting that 55,000 shares of Issuers stock attributed to John Lames IRA were beneficially owned by Susan Lames IRA.

Mr. Lame is a citizen of the United States and his principal occupation is Chief Executive Officer of Untapped, LLC, a limited liability company. The principal business of Untapped, LLC is life guidance and wealth coaching.

Ms. Lame is a citizen of the United States and her principal occupation is special projects manager, Untapped, LLC. The principal business of Untapped, LLC is life guidance and wealth coaching.

The Trust is an irrevocable trust established by John C. Lame and Susan K. Lame as a testamentary trust for estate planning purposes. The John C. Lame IRA, the John Lame Roth IRA, the Susan K. Lame IRA, and the Susan Lame Roth IRA are retirement accounts established by Mr. and Mrs. Lame.

The address of each Reporting Person for purposes of this filing is: 8805 Tamiami Trail N. #128, Naples, Florida 34108.

By virtue of these relationships and pursuant to the beneficial ownership rules of the SEC, the Reporting Persons may be deemed to be members of a group.

The Reporting Persons have not, during the past five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting, or mandating activities subject to, federal or state securities laws or a finding of any violation with respect to such laws.

 

Item 3.

Source and Amount of Funds or Other Consideration

The Trust purchased shares of the Issuers common stock using Trust funds. Commencing August 2, 2021, some of the shares purchased by the Trust were purchased through a margin account with Charles Schwab & Co., Inc. Shares of the Issuers common stock held in the Trust margin account are held as collateral for repayment of the margin debt, and accordingly an indeterminate portion of the margin debt at any given point in time is attributable to the Issuers common stock held by the Trust. With the exception of 26,000 shares transferred for no consideration from the Susan K. Lame IRA to the Susan Lame Roth IRA on January 10, 2022, shares of the Issuers common stock held directly by the Trust, the John C. Lame IRA, the John Lame Roth IRA, the Susan K. Lame IRA, and the Susan Lame Roth IRA were acquired directly by these reporting persons. Shares of the Issuer are listed on the Nasdaq Capital Market under the symbol LCNB.

 

Item 4.

Purpose of the Transaction

As specifically set forth herein, this Amendment No. 3 amends the Schedule 13D filed on July 30, 2021, as amended by the filing of Amendments No. 1 and No. 2, respectively, on October 21, 2021 and November 22, 2021. This Amendment No. 3 is being filed to reflect a change in the percentage of outstanding shares of the Issuer held by the Reporting Persons resulting from the additional 127,325 shares acquired by the Reporting Persons through open-market purchases. The Reporting Persons beneficial ownership increased by 1.02% of the outstanding shares of the

 

7

CUSIP No. 50181P100

 

Issuer from that previously reported. As of the Schedule 13D Amendment No. 2 filing date, the Reporting Persons collectively owned 900,000 shares of the Issuers common stock, which represented 7.24% of the outstanding shares of the Issuer.    With ownership of 1,027,325 shares reported in this Amendment No. 3, the percentage of outstanding shares of the Issuer that the Reporting Persons holdings represent has increased to 8.26%, causing the need to file this Amendment No. 3.    

The Reporting Persons reserve the right to purchase or otherwise acquire additional securities of the Issuer, or sell or otherwise dispose of any securities of the Issuer beneficially owned by them, in each case, in the open market or in privately negotiated transactions, to the extent deemed advisable in light of market conditions, subsequent developments affecting the Issuer and the general business and future prospects of the Issuer.

 

Item 5.

Interest in Securities of the Issuer

Item 5(a) (b) is hereby amended as follows:

(a) (b)    According to the Issuers Form 10-Q filed with the SEC on November 3, 2021, there were 12,433,328 shares of the Issuers common stock outstanding on September 30, 2021.

The following list sets forth the aggregate number and percentage of outstanding shares of the Issuers common stock owned beneficially by each Reporting Person:

 

Name		No. of Shares				Percent of Class
John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018			695,000	(1)			5.59	%
John C. Lame IRA			144,580	(2)			1.16	%
John C. Lame Roth IRA			83,170	(2)			.67	%
Susan K. Lame Roth IRA			48,450	(3)			.39	%
Susan K. Lame IRA			56,125	(3)			.45	%
TOTAL			1,027,325				8.26	%

 

(1)	John C. Lame and Susan K. Lame are joint trustees and have shared investment and voting authority with respect to these shares.

(2)	John C. Lame has sole investment and voting authority with respect to these shares.

(3)	Susan K. Lame has sole investment and voting authority with respect to these shares.

(c) The Reporting Persons transactions in the Issuers common stock in the past 60 days consist of the following purchases.

Since Amendment No. 2 was filed on November 22, 2021, the following open-market transactions were effected by the Trust during the past sixty (60) days:    

 

Trade Date		Buy/Sell				Number of Shares				Price Per Share
1/19/2022			Buy				1520			$	19.67
1/19/2022			Buy				50			$	19.75
1/19/2022			Buy				499			$	19.77
1/19/2022			Buy				2251			$	19.78

 

8

CUSIP No. 50181P100

 

1/19/2022			Buy				200			$	19.79
1/19/2022			Buy				100			$	19.80
1/19/2022			Buy				184			$	19.83
1/19/2022			Buy				98			$	19.84
1/19/2022			Buy				618			$	19.87
12/31/2021			Buy				8900			$	19.65
12/31/2021			Buy				1000			$	19.63
12/31/2021			Buy				1000			$	19.40
12/31/2021			Buy				1000			$	19.49
12/31/2021			Buy				100			$	19.59
12/31/2021			Buy				1000			$	19.69

Since Amendment No. 2 was filed on November 22, 2021, the following open-market transactions were effected by the John Lame IRA during the past sixty (60) days:

 

Trade Date		Buy/Sell				Number of Shares				Price Per Share
12/20/2021			Buy				1100			$	18.98
12/20/2021			Buy				160			$	19.13
12/20/2021			Buy				100			$	19.19
12/20/2021			Buy				344			$	19.20
12/20/2021			Buy				76			$	19.24
11/30/2021			Buy				1000			$	19.00
11/30/2021			Buy				2000			$	19.21
11/29/2021			Buy				306			$	19.78
11/29/2021			Buy				194			$	19.81
11/29/2021			Buy				200			$	19.83
11/29/2021			Buy				100			$	19.84
11/29/2021			Buy				300			$	19.88
11/29/2021			Buy				10			$	19.89
11/29/2021			Buy				2414			$	19.90
11/29/2021			Buy				300			$	19.91
11/29/2021			Buy				860			$	19.92
11/29/2021			Buy				180			$	19.96
11/29/2021			Buy				436			$	19.97
11/29/2021			Buy				400			$	19.98
11/29/2021			Buy				200			$	19.99
11/29/2021			Buy				14100			$	20.00
11/26/2021			Buy				100			$	19.97
11/26/2021			Buy				1000			$	19.98
11/26/2021			Buy				150			$	20.00
11/26/2021			Buy				1050			$	20.01
11/26/2021			Buy				8700			$	20.10
11/24/2021			Buy				20			$	19.58
11/24/2021			Buy				2			$	19.61
11/24/2021			Buy				600			$	19.71

 

9

CUSIP No. 50181P100

 

11/24/2021			Buy				100			$	19.72
11/24/2021			Buy				500			$	19.73
11/24/2021			Buy				1819			$	19.74
11/24/2021			Buy				168			$	19.75
11/24/2021			Buy				1080			$	19.80
11/24/2021			Buy				1			$	19.81
11/24/2021			Buy				50			$	19.88
11/24/2021			Buy				334			$	19.95
11/24/2021			Buy				6684			$	19.96
11/24/2021			Buy				2201			$	19.97
11/24/2021			Buy				2441			$	20.00
11/24/2021			Buy				400			$	20.16
11/24/2021			Buy				17			$	20.20
11/24/2021			Buy				1356			$	20.38
11/24/2021			Buy				2564			$	20.39
11/24/2021			Buy				100			$	20.43
11/24/2021			Buy				300			$	20.46
11/24/2021			Buy				700			$	20.59
11/24/2021			Buy				120			$	20.60
11/24/2021			Buy				50			$	20.64
11/24/2021			Buy				200			$	20.65
11/24/2021			Buy				1060			$	20.66
11/24/2021			Buy				205			$	20.67
11/24/2021			Buy				928			$	20.69
11/22/2021			Buy				27			$	19.49
11/22/2021			Buy				700			$	19.51
11/22/2021			Buy				999			$	19.52
11/22/2021			Buy				4			$	19.53
11/22/2021			Buy				18			$	19.55
11/22/2021			Buy				11			$	19.56
11/22/2021			Buy				869			$	19.57
11/22/2021			Buy				2372			$	19.58
11/22/2021			Buy				2500			$	19.76
11/22/2021			Buy				58			$	19.85
11/22/2021			Buy				100			$	19.86
11/22/2021			Buy				300			$	19.87
11/22/2021			Buy				1395			$	19.88
11/22/2021			Buy				1100			$	19.89
11/22/2021			Buy				1447			$	19.92
11/22/2021			Buy				100			$	19.98
11/22/2021			Buy				600			$	19.99
11/22/2021			Buy				7400			$	20.00

 

10

CUSIP No. 50181P100

 

Since Amendment No. 2 was filed on November 22, 2021, the following open-market transactions were effected by the John Lame Roth IRA during the past sixty (60) days:

 

Trade Date		Buy/Sell				Number of Shares				Price Per Share
12/20/2021			Buy				600			$	18.98
12/20/2021			Buy				675			$	19.06
12/20/2021			Buy				100			$	19.10
12/20/2021			Buy				75			$	19.13

Since Amendment No. 2 was filed on November 22, 2021, the following open-market transactions were effected by the Susan Lame Roth IRA during the past sixty (60) days:

 

Trade Date

Buy/Sell

Number of Shares

Price Per Share

12/20/2021

Buy

450

$

19.06

Since Amendment No. 2 was filed on November 22, 2021, the following open-market transactions were effected by the Susan Lame IRA during the past sixty (60) days:

 

Trade Date		Buy/Sell				Number of Shares				Price Per Share
12/27/2021			Buy				1000			$	20.11
12/27/2021			Buy				1000			$	20.07
12/27/2021			Buy				140			$	20.04
12/27/2021			Buy				860			$	20.01
12/27/2021			Buy				100			$	19.94
12/27/2021			Buy				200			$	19.91
12/27/2021			Buy				700			$	19.90
12/20/2021			Buy				1125			$	19.06
12/17/2021			Buy				749			$	19.80
12/17/2021			Buy				1000			$	19.78
12/17/2021			Buy				225			$	19.77
12/17/2021			Buy				26			$	19.74
12/17/2021			Buy				388			$	19.71
12/17/2021			Buy				13000			$	19.65
12/17/2021			Buy				592			$	19.60
12/17/2021			Buy				20			$	19.54
12/17/2021			Buy				1000			$	19.53
12/17/2021			Buy				884			$	19.48
12/17/2021			Buy				77			$	19.46
12/17/2021			Buy				39			$	19.32
12/17/2021			Buy				791			$	19.29
12/17/2021			Buy				209			$	19.28
12/17/2021			Buy				1375			$	19.27
12/17/2021			Buy				1101			$	19.26
12/17/2021			Buy				132			$	19.24
12/17/2021			Buy				392			$	19.21

 

11

CUSIP No. 50181P100

 

(d) No one other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends or proceeds of sale of the shares.

(e) not applicable

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Other than as described herein, there are no contracts, arrangements, understandings or relationships (legal or

otherwise) between the Reporting Persons and any person with respect to any securities of the Issuer, including,

but not limited to, transfer or voting of any of the securities, finders fees, joint ventures, loan or option

arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

 

Item 7.

Material to Be Filed as Exhibits

 

Exhibit Number		Description
99.1		Joint Filing Agreement among John C. Lame IRA, John C. Lame Roth Contributory IRA, Susan K. Lame IRA, Susan K. Lame Roth Contributory IRA, and John C. Lame and Susan K. Lame as trustees of the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018.

 

12

CUSIP No. 50181P100

 

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: January 19, 2022

 

 

 

13